164 related articles for article (PubMed ID: 21326320)
1. The human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage site.
Stickler MM; Reddy A; Xiong JM; Hinton PR; DuBridge R; Harding FA
Genes Immun; 2011 Apr; 12(3):213-21. PubMed ID: 21326320
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the ability of the human IgG1 allotypes G1m3 and G1m1,17 to stimulate T-cell responses from allotype matched and mismatched donors.
Webster CI; Bryson CJ; Cloake EA; Jones TD; Austin MJ; Karle AC; Spindeldreher S; Lowe DC; Baker MP
MAbs; 2016; 8(2):253-63. PubMed ID: 26821574
[TBL] [Abstract][Full Text] [Related]
3. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of CD4
Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
Front Immunol; 2020; 11():602014. PubMed ID: 33658991
[TBL] [Abstract][Full Text] [Related]
5. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
[TBL] [Abstract][Full Text] [Related]
6. Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms.
Fujita H; Senju S; Yokomizo H; Saya H; Ogawa M; Matsushita S; Nishimura Y
Eur J Immunol; 1998 Jan; 28(1):305-16. PubMed ID: 9485210
[TBL] [Abstract][Full Text] [Related]
7. Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study.
Bartelds GM; de Groot E; Nurmohamed MT; Hart MH; van Eede PH; Wijbrandts CA; Crusius JB; Dijkmans BA; Tak PP; Aarden L; Wolbink GJ
Arthritis Res Ther; 2010; 12(6):R221. PubMed ID: 21187010
[TBL] [Abstract][Full Text] [Related]
8. Epitope characterization of pre-existing and developing antibodies to an aglycosylated monoclonal antibody therapeutic of G1m17,1 allotype.
Tatarewicz SM; Juan G; Swanson SJ; Moxness MS
J Immunol Methods; 2012 Aug; 382(1-2):93-100. PubMed ID: 22609464
[TBL] [Abstract][Full Text] [Related]
9. Alternative G1m, G2m and G3m allotypes of IGHG genes correlate with atopic and nonatopic pathways of immune regulation in children with bronchial asthma.
Oxelius VA; Carlsson AM; Aurivillius M
Int Arch Allergy Immunol; 1998 Mar; 115(3):215-9. PubMed ID: 9531163
[TBL] [Abstract][Full Text] [Related]
10. Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.
Wallace LE; Wright J; Ulaeto DO; Morgan AJ; Rickinson AB
J Virol; 1991 Jul; 65(7):3821-8. PubMed ID: 1710291
[TBL] [Abstract][Full Text] [Related]
11. Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.
Moro M; Cecconi V; Martinoli C; Dallegno E; Giabbai B; Degano M; Glaichenhaus N; Protti MP; Dellabona P; Casorati G
BMC Immunol; 2005 Dec; 6():24. PubMed ID: 16329759
[TBL] [Abstract][Full Text] [Related]
12. The heterogeneity of bovine IgG2--V. Differences in the primary structure of bovine IgG2 allotypes.
Heyermann H; Butler JE; Frangione B
Mol Immunol; 1992 Sep; 29(9):1147-52. PubMed ID: 1495501
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effect of synthetic peptides corresponding to sequences within the CH2 and CH3 domain of human IgG1.
Sàrmay G; Reguly K; Szigeti R; Klein E; Stanworth DR; Gergely J
Mol Immunol; 1988 Nov; 25(11):1183-8. PubMed ID: 3146695
[TBL] [Abstract][Full Text] [Related]
14. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.
Wang M; Larsen MV; Nielsen M; Harndahl M; Justesen S; Dziegiel MH; Buus S; Tang ST; Lund O; Claesson MH
PLoS One; 2010 May; 5(5):e10533. PubMed ID: 20479886
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence that peptide vaccination can induce HLA-DR-restricted CD4+ T cells reactive to a class I tumor peptide.
Harada M; Gohara R; Matsueda S; Muto A; Oda T; Iwamoto Y; Itoh K
J Immunol; 2004 Feb; 172(4):2659-67. PubMed ID: 14764741
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles.
Shams H; Klucar P; Weis SE; Lalvani A; Moonan PK; Safi H; Wizel B; Ewer K; Nepom GT; Lewinsohn DM; Andersen P; Barnes PF
J Immunol; 2004 Aug; 173(3):1966-77. PubMed ID: 15265931
[TBL] [Abstract][Full Text] [Related]
17. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells.
Zarour HM; Storkus WJ; Brusic V; Williams E; Kirkwood JM
Cancer Res; 2000 Sep; 60(17):4946-52. PubMed ID: 10987311
[TBL] [Abstract][Full Text] [Related]
18. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope.
Olive M; Eisenlohr L; Flomenberg N; Hsu S; Flomenberg P
Hum Gene Ther; 2002 Jul; 13(10):1167-78. PubMed ID: 12133270
[TBL] [Abstract][Full Text] [Related]
19. Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries.
Osen W; Soltek S; Song M; Leuchs B; Steitz J; Tüting T; Eichmüller SB; Nguyen XD; Schadendorf D; Paschen A
PLoS One; 2010 Nov; 5(11):e14137. PubMed ID: 21152437
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.
Kratochvil S; McKay PF; Chung AW; Kent SJ; Gilmour J; Shattock RJ
Front Immunol; 2017; 8():1883. PubMed ID: 29326728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
